Autonomix to present at the medinvest biotech & pharma investor conference

Live webcast presentation on thursday, april 4 th at 3:55 pm et the woodlands, tx, march 27, 2024 (globe newswire) -- autonomix medical, inc. (nasdaq: amix) (“autonomix” or the “company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that lori bisson, chief executive officer of autonomix, will present at the medinvest biotech & pharma investor conference being held in new york city, ny on thursday, april 4, 2024 at 3:55 pm et. in addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference.
AMIX Ratings Summary
AMIX Quant Ranking